CLINICAL ROLE -
Etanercept and Ustekinumab Dosing for Psoriasis and Psoriatic Arthritis
For patients with psoriasis and/or psoriatic arthritis, actual-to-expected dosing ratios and costs were lower for etanercept than for ustekinumab.
Compliance and Cost of Biologic Therapies for Rheumatoid Arthritis
Medication compliance is associated with lower overall and disease-related healthcare costs in patients with moderate to severe rheumatoid arthritis receiving biologic therapies.
Effectiveness and Costs of Biologics in Veterans With Rheumatoid Arthritis
This study applied a validated algorithm to estimate the effectiveness and costs of the index biologic used by 4696 US veterans with rheumatoid arthritis.
2 Clarke Drive Cranbury, NJ 08512